Drummond M, Maynard A
Health Policy. 1988;9(1):59-74. doi: 10.1016/0168-8510(88)90118-2.
Although the NHS gives relatively good value for money when compared to other countries' health care systems, there are managerial initiatives from abroad that could potentially increase NHS efficiency. However, there is currently very little systematic evaluation of the impact of managerial interventions in terms of their benefits and costs. This paper considers four areas of current policy interest (evaluation of new medical technologies, quality assurance, primary health care and the public/private mix), reviews experience abroad and outlines how promising initiatives could be evaluated in the NHS setting. It is argued that if lessons are to be learned about the efficient management of the NHS from abroad or not, there needs to be more systematic evaluation of managerial interventions along the lines commonly proposed for clinical interventions.
尽管与其他国家的医疗保健系统相比，英国国家医疗服务体系（NHS）性价比相对较高，但国外的管理举措有可能提高NHS的效率。然而，目前对于管理干预措施的效益和成本影响，几乎没有系统的评估。本文考虑了当前政策关注的四个领域（新医疗技术评估、质量保证、初级医疗保健以及公私合作模式），回顾了国外的经验，并概述了如何在NHS环境中对有前景的举措进行评估。有人认为，无论是否要从国外汲取NHS高效管理的经验教训，都需要按照通常针对临床干预措施所提议的方式，对管理干预措施进行更系统的评估。
